Literature DB >> 12946015

Latrogenic Creutzfeldt-Jakob disease with florid plaques.

Hans A Kretzschmar1, Shneh Sethi, Zsuzsanna Földvári, Otto Windl, Veronika Querner, Inga Zerr, Sigrid Poser.   

Abstract

Florid plaques indistinguishable from those found in vCJD were identified at a postmortem examination in the brain of a 58-year-old clinical suspect case of Creutzfeldt-Jakob disease (CJD). Western blotting of brain tissue revealed an unusual prion protein type. Since the patient had received a dura mater graft 20 years prior to death and florid plaques are not only found in new variant CJD, the findings argue in favor of an iatrogenic origin of the disease with the longest incubation time following a dura mater graft reported to date even though he may have been exposed to BSE. The peculiar pathological, clinical and biochemical features may define a new type of human prion disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12946015     DOI: 10.1111/j.1750-3639.2003.tb00025.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  11 in total

1.  Distinctive properties of plaque-type dura mater graft-associated Creutzfeldt-Jakob disease in cell-protein misfolding cyclic amplification.

Authors:  Atsuko Takeuchi; Atsushi Kobayashi; Piero Parchi; Masahito Yamada; Masanori Morita; Shusei Uno; Tetsuyuki Kitamoto
Journal:  Lab Invest       Date:  2016-02-15       Impact factor: 5.662

2.  Experimental verification of a traceback phenomenon in prion infection.

Authors:  Atsushi Kobayashi; Nobuyuki Sakuma; Yuichi Matsuura; Shirou Mohri; Adriano Aguzzi; Tetsuyuki Kitamoto
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

3.  Alzheimer-type neuropathology in a 28 year old patient with iatrogenic Creutzfeldt-Jakob disease after dural grafting.

Authors:  M Preusser; T Ströbel; E Gelpi; M Eiler; G Broessner; E Schmutzhard; H Budka
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

4.  MRI and clinical syndrome in dura mater-related Creutzfeldt-Jakob disease.

Authors:  B Meissner; K Kallenberg; P Sanchez-Juan; S Ramljak; A Krasnianski; U Heinemann; S Eigenbrod; E Gelpi; B Barsic; H A Kretzschmar; W J Schulz-Schaeffer; M Knauth; I Zerr
Journal:  J Neurol       Date:  2009-01-23       Impact factor: 4.849

Review 5.  Neuroimaging findings in human prion disease.

Authors:  R G Macfarlane; S J Wroe; J Collinge; T A Yousry; H R Jäger
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-29       Impact factor: 10.154

6.  Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone.

Authors:  Ignazio Cali; Cathleen J Miller; Joseph E Parisi; Michael D Geschwind; Pierluigi Gambetti; Lawrence B Schonberger
Journal:  Acta Neuropathol Commun       Date:  2015-06-25       Impact factor: 7.801

Review 7.  Distinct origins of dura mater graft-associated Creutzfeldt-Jakob disease: past and future problems.

Authors:  Atsushi Kobayashi; Yuichi Matsuura; Shirou Mohri; Tetsuyuki Kitamoto
Journal:  Acta Neuropathol Commun       Date:  2014-03-31       Impact factor: 7.801

8.  Deciphering the pathogenesis of sporadic Creutzfeldt-Jakob disease with codon 129 M/V and type 2 abnormal prion protein.

Authors:  Atsushi Kobayashi; Yasushi Iwasaki; Hiroyuki Otsuka; Masahito Yamada; Mari Yoshida; Yuichi Matsuura; Shirou Mohri; Tetsuyuki Kitamoto
Journal:  Acta Neuropathol Commun       Date:  2013-11-13       Impact factor: 7.801

9.  Characterization of Sporadic Creutzfeldt-Jakob Disease and History of Neurosurgery to Identify Potential Iatrogenic Cases.

Authors:  Tsuyoshi Hamaguchi; Kenji Sakai; Atsushi Kobayashi; Tetsuyuki Kitamoto; Ryusuke Ae; Yosikazu Nakamura; Nobuo Sanjo; Kimihito Arai; Mizuho Koide; Fumiaki Katada; Masafumi Harada; Hiroyuki Murai; Shigeo Murayama; Tadashi Tsukamoto; Hidehiro Mizusawa; Masahito Yamada
Journal:  Emerg Infect Dis       Date:  2020-06       Impact factor: 6.883

Review 10.  Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine.

Authors:  Gabor G Kovacs
Journal:  Int J Mol Sci       Date:  2016-02-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.